Replies to post #385967 on NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

I do not believe NWBO wants to withhold the data forever and I do hope that this rule will put some pressure on them and they realize that there is a beginning and legal end how long they can wait which will make them see the urgency.

It would be stranger than Edmund Elias Merhiges "Begotten".

It would contradict "TLD in coming months".

Hiring Kristin Power and Tamara Kondic, makes no sense.

Borrowing $11 mio. with repayments November 2021, must be for the submarine escape to South America.

3 PRs and an ASM with a clear message of 6 stages and publication, which are all lies.

And on the sidelines application for MHRA Sawston, patent for DCVAX-Direct and Flaskworks patents. All for diversion purposes.

People should enjoy the wait. Lovely things will happen.

[ahp123]

Well She/the company is already in Direct contradiction with alt of the rules of 42 CFR part 11, just look at this “ General Requirements (42 CFR Part 11)
• The responsible party for an applicable clinical trial (ACT) must:
– Register the ACT on ClinicalTrials.gov no later than 21 days after enrollment of the first participant;
– Update the ACT on ClinicalTrials.gov at least once every 12 months with some items requiring update within 15 or 30 days of a change (e.g., Recruitment Status, Primary Completion Date within 30 days)
– Submit summary results (including adverse event information) not later than 1 year after the trial’s Primary Completion Date, with delays allowed in some circumstances
So if they have new endpoint it should be listed… but as everybody knows, Linda doesnt give a s… about rules…